Incorporating laparoscopic interval cytoreductive surgery for advanced ovarian cancer-lessons learnt
Objective: To assess the utility of laparoscopy for interval cytoreductive surgery (CRS) in patients with advanced ovarian cancer after Neo-Adjuvant Chemotherapy (NACT). Methods: A retrospective cohort study of interval CRS by laparoscopy in patients with advanced epithelial ovarian cancer treated a...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-12-01
|
| Series: | Clinical Surgical Oncology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2773160X2300020X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Objective: To assess the utility of laparoscopy for interval cytoreductive surgery (CRS) in patients with advanced ovarian cancer after Neo-Adjuvant Chemotherapy (NACT). Methods: A retrospective cohort study of interval CRS by laparoscopy in patients with advanced epithelial ovarian cancer treated at a single tertiary gynaecological cancer centre between October 2017 and September 2020. Results: 86 patients had interval CRS by the laparoscopic route during the study period. The optimal cytoreduction rate (R < 1 cm) was 92%, and complete cytoreduction rate with no residual disease (R = 0) was 35%. The intra-operative complication rate was 8% and the estimated blood loss (EBL) was 90 ml. The post-operative complication rate was 15%, mostly grade I-II, and the median length of hospital stay was 3 days. Conclusion: For most patients with advanced ovarian cancer after NACT, laparoscopic interval CRS is feasible and effective in achieving optimal cytoreduction while providing a favourable peri-operative outcome. In some cases, however, recourse to laparotomy will optimise complete macroscopic resection. |
|---|---|
| ISSN: | 2773-160X |